| Ashley Kym Smart, MCD, CCC-SLP | |
|
1910 Coleman Rd, Anniston, AL 36207-6816 | |
| (256) 240-8801 | |
| Not Available |
| Full Name | Ashley Kym Smart |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1910 Coleman Rd, Anniston, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194265272 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2855 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Kym Smart, MCD, CCC-SLP 1910 Coleman Rd, Anniston, AL 36207-6816 Ph: () - | Ashley Kym Smart, MCD, CCC-SLP 1910 Coleman Rd, Anniston, AL 36207-6816 Ph: (256) 240-8801 |
News Archive
Patients with coronary heart disease who took Lipitor (atorvastatin calcium) 80 mg tablets reduced their risk of hospitalizations due to heart failure compared to patients taking the 10 mg dose of Lipitor, according to a new analysis of a subset of patients from the five-year TNT (Treating to New Targets) study, published in today's issue of Circulation.
BugLab LLC, the industry leader in non-invasive optical monitoring, has introduced the OD Scanner – the world's first handheld sensor for measuring optical density in shake flasks and other small vessels. This device removes the need to open shake flasks to measure optical density (OD). Instead, by directly measuring OD through the container wall, the labor, contamination risk, and inaccuracy associated with sampling and dilution are eliminated.
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
With $9.7 million in funding from the National Eye Institute, researchers at the University of Illinois at Chicago will study the impact of chronic eye disease among Latinos.
› Verified 7 days ago
Amanda Marable, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 415 Castle Ave, Anniston, AL 36205 Phone: 256-237-8203 Fax: 256-235-2388 | |
Caroline Brook, MS, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 731 Leighton Ave, Anniston, AL 36207 Phone: 256-235-5155 Fax: 256-235-5590 | |
Julie M Rismiller, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 E 10th St, Anniston, AL 36207 Phone: 256-235-5860 | |
Mrs. Rena D. Schoenberg, M. A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1265 Ravenwood Dr, Anniston, AL 36207 Phone: 256-239-1335 | |
Savannah Taylor, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3331 Henry Road, Anniston, AL 36207 Phone: 256-624-6377 | |
Deborah Mcbee, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2300 Coleman Rd, Anniston, AL 36207 Phone: 256-831-5730 |